CN103705596A - Traditional Chinese medicine for reducing blood pressure and preparation method thereof - Google Patents
Traditional Chinese medicine for reducing blood pressure and preparation method thereof Download PDFInfo
- Publication number
- CN103705596A CN103705596A CN201410011280.6A CN201410011280A CN103705596A CN 103705596 A CN103705596 A CN 103705596A CN 201410011280 A CN201410011280 A CN 201410011280A CN 103705596 A CN103705596 A CN 103705596A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese
- traditional chinese
- class
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 230000036772 blood pressure Effects 0.000 title abstract description 6
- 230000001603 reducing effect Effects 0.000 title abstract 4
- 210000000582 semen Anatomy 0.000 claims abstract description 18
- 230000001737 promoting effect Effects 0.000 claims abstract description 15
- 230000017531 blood circulation Effects 0.000 claims abstract description 14
- 238000010828 elution Methods 0.000 claims abstract description 13
- 239000012535 impurity Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 238000000605 extraction Methods 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 18
- 208000004880 Polyuria Diseases 0.000 claims description 13
- 230000035619 diuresis Effects 0.000 claims description 13
- 230000001476 alcoholic effect Effects 0.000 claims description 12
- 239000003480 eluent Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 8
- 241000218176 Corydalis Species 0.000 claims description 7
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 7
- 230000000274 adsorptive effect Effects 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 229920005989 resin Polymers 0.000 claims description 6
- 239000011347 resin Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 6
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 230000001631 hypertensive effect Effects 0.000 abstract description 5
- 230000008506 pathogenesis Effects 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 2
- 239000002934 diuretic Substances 0.000 abstract description 2
- 230000001882 diuretic effect Effects 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 241001571446 Scaphium scaphigerum Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000005555 hypertensive agent Substances 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 244000037364 Cinnamomum aromaticum Species 0.000 description 4
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 4
- 241000245240 Lonicera Species 0.000 description 4
- 241000133222 Lychnophora Species 0.000 description 4
- 241001529739 Prunella <angiosperm> Species 0.000 description 4
- 229940126678 chinese medicines Drugs 0.000 description 4
- 208000013403 hyperactivity Diseases 0.000 description 4
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 241000545442 Radix Species 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 108010061435 Enalapril Proteins 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- GBXSMTUPTTWBMN-XIRDDKMYSA-N enalapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(O)=O)CC1=CC=CC=C1 GBXSMTUPTTWBMN-XIRDDKMYSA-N 0.000 description 2
- 229960000873 enalapril Drugs 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 241000668709 Dipterocarpus costatus Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 206010019013 Haemorrhagic infarction Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 206010054805 Macroangiopathy Diseases 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 description 1
- 229940126317 angiotensin II receptor antagonist Drugs 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 206010062198 microangiopathy Diseases 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for reducing blood pressure. The traditional Chinese medicine comprises the following traditional Chinese medicines in parts by weight: 5-12 parts of medicines for promoting blood circulation to remove meridian obstruction, 5-10 parts of medicines for nourishing and suppressing Yang, 8-15 parts of diuretic medicines, 5-12 parts of semen cassiae, 4-8 parts of honeysuckle, 2-5 parts of selfheal, 1-5 parts of astragalus membranaceus, 5-8 parts of scaphium scaphigerum and 3-8 parts of hawthorn. According to pathogenesis, pathogeny and complications of hypertension, the traditional Chinese medicines are combined in certain parts by weight, so that not only can the blood pressure reducing effect be remarkable, but also the blood fat adjusting effect is further relatively remarkable, thereby having remarkable meaning for delaying progression of disease and complications of hypertension. The preparation process of the traditional Chinese medicine for reducing blood pressure comprises extraction, filtration and concentration, elution and drying. Not only is the preparation method simple, but also the purity of the traditional Chinese medicine is effectively improved. Meanwhile, a user is prevented from being damaged by various impurities. The medicine provided by the invention is free from toxic and side effects, and especially suitable for hypertensives to use for a long time.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of hypertensive Chinese medicine and preparation method thereof that is used for the treatment of.
Background technology
Hypertension is common a kind of cardiovascular disease, the development of the hypertension state of an illness can cause multiple complications, and the most common is the microangiopathies such as the macroangiopathies such as the heart changes such as left ventricular hypertrophy, coronary heart disease, hemorrhagic and cerebral infarction, arteriosclerosis, retinal arteriosclerosis and optical fundus change.And wherein cerebrovascular disease is a kind of pathological changes the most common in high blood pressure disease evolution, it is also the major reason that causes hyperpietic's death.Change along with people life style, Hypertension incidence increases year by year, the data of announcing according to health ministry show, within 2004, China hyperpietic surpasses 1.6 hundred million, and hyperpietic is still increasing with annual 3500000 people's speed, according to WHO statistics, show, global hyperpietic accounts for the more than 11% of total population.Hypertension is common with middle-older patient, but in recent years, along with the increase of people's life stress and the change of daily life, hyperpietic is rejuvenation more and more.As can be seen here, hypertension has to cause our attention and concern for the threat of human health.
At present, hypertensive western medical treatment is main mainly with enalapril meleate, current enalapril meleate mainly comprises diuretic, vasodilation, alpha-blocking agent, beta-blocker, Angiotensin Ⅱ receptor antagonist and hypertensinase converting enzyme inhibitor etc., hyperpietic need take medicine throughout one's life, but the above-mentioned Western medicine of long-term taking easily produces drug resistance, and can produce injury to patient body, simultaneously, when taking above-mentioned depressor, also easily cause that blood vessel control is unstable, cause fluctuation of blood pressure, cause cerebrovascular disease, bring larger threat to patient's life security.
Hypertension belongs to the traditional Chinese medical science " dizzy " " liver-yang " category, pathogenesis be feelings will internal injury, hepatic and renal YIN deficiency yang hyperactivity or eating and drinking without temperance, the turbid heap soil or fertilizer over and around the roots of expectorant stagnant due to, therefore, during Chinese traditional treatment, should take nourishing YIN and subduing the hyperactivity of liver-YANG or expectorant damp eliminating is Therapeutic Principle.Differential diagnosis in tcm is divided into hyperactivity of YANG due to deficiency of YIN and deficiency of both YIN and YANG amphitypy by hypertension, and traditional Chinese traditional treatment adopts attached osmanthus eight taste pill for curing type of deficiency of YIN leading to hyper activity of YANGs, adopt nourishing YIN Yang Promoting Decoction treatment deficiency of both YIN and YANG type, but treated effect is only 40%-70% left and right.Therefore,, for the current integrative therapy present situation of hypertension, be badly in need of at present finding and to work out a kind of hypertension therapeutic for the treatment of effective, the Chinese medicine preparation that treated effect is high and safe.
Summary of the invention
For solving above-mentioned the deficiencies in the prior art, want, the invention provides a kind of Chinese hypotensor and preparation method,
Technical scheme of the present invention is as follows:
A Chinese hypotensor, described Chinese hypotensor is comprised of the Chinese medicine of following weight portion proportioning:
Described promoting blood circulation to remove obstruction in the collateral class is selected from one or more in Radix Curcumae, Rhizoma Chuanxiong, Rhizoma Corydalis, the Radix Paeoniae Alba or Radix Salviae Miltiorrhizae.
The ratio of the weight portion of described Radix Curcumae, Rhizoma Chuanxiong, Rhizoma Corydalis, the Radix Paeoniae Alba or Radix Salviae Miltiorrhizae is (1-3): (2-5): (1.5-3.5): (1.5-4.5): (2-6).
Described nourishing YIN for suppressing the hyperactive YANG class is selected from one or more in Concha Ostreae or Os Draconis.
The ratio of described Concha Ostreae or the weight portion of Os Draconis is (1.5-5.5): (2-5).
Described diuresis class is selected from one or more in Rhizoma Alismatis, Radix Rehmanniae Preparata, Poria, Folium Nelumbinis or Exocarpium Benincasae.
The ratio of the weight portion of described Rhizoma Alismatis, Radix Rehmanniae Preparata, Poria, Folium Nelumbinis or Exocarpium Benincasae is (1-5): (1-5): (3.5-5.5): (1.5-4.5): (2-4.5).
A preparation method for above-mentioned Chinese hypotensor, comprises the following steps:
(1) take by weight promoting blood circulation to remove obstruction in the collateral class 5-12 part, nourishing YIN for suppressing the hyperactive YANG class 5-10 part, diuresis class 8-15 part, Semen Cassiae 5-12 part, Flos Lonicerae 4-8 part, Spica Prunellae 2-5 part, Radix Astragali 1-5 part, Semen Sterculiae Lychnophorae 5-8 part, Fructus Crataegi 3-8 part, be ground into fine powder, cross 60 mesh sieves, add solvent to extract, obtain extracting solution;
(2) in the extracting solution making in step (1), add solvent to carry out filtering and concentrating, to remove impurity, obtain concentrated solution;
(3) to the concentrated solution making in step (2), adopt macroporous adsorptive resins to carry out eluting, eluting 2 times, obtains eluent;
(4) eluent making in step (3) is dried and makes Chinese medicinal powder;
(5) Chinese medicinal powder making in step (4) is processed, made pill, tablet capsule, slow releasing pill, slow releasing tablet, slow releasing capsule.
Preferably, the solvent described in step (1) is purified water, and the temperature of extraction is 65-80 ℃, and the time of extraction is 30-45min; Solvent described in step (2) is that concentration is the alcoholic solution of 45%-50%, and concentrated temperature is 65-80 ℃, and the concentrated time is 30-45min.
Preferably, the alcoholic solution that the desorbing agent adopting during eluting in step (3) is 20-30%, elution flow rate is 0.6-0.8BV/h, and elution time is 20-30min, and eluting temperature is 50-60 ℃.
Compared with prior art, beneficial effect of the present invention has:
1. hyperpietic is in hypertension, because the course of disease is long, prolonged illness is to deficiency of kidney yin, liver-fire is partially prosperous, and hyperpietic is common with middle-older patient, often with hyperlipidemia, in addition, hyperpietic also easily merges arteriosclerosis, easily there is cerebral hemorrhage or cerebral ischemia, coronary heart disease, the present invention is according to hypertensive morbidity pathogenesis, pathogeny and complications, by promoting blood circulation to remove obstruction in the collateral class, nourishing YIN for suppressing the hyperactive YANG class, diuresis class, Semen Cassiae, Flos Lonicerae, Spica Prunellae, the Radix Astragali, Semen Sterculiae Lychnophorae and Fructus Crataegi compatibility are used, wherein Semen Cassiae has good hypotensive effect, but also there is obvious antiplatelet aggregation, reduce blood viscosity, vascular lesion for prophylaxis of hypertension patient is significant, simultaneously Semen Cassiae also can removing heat from the liver, adjust blood fat.Spica Prunellae has the effect that suppresses renin activity, also plays obvious hypotensive effect.Semen Sterculiae Lychnophorae can eliminate the phlegm in spleen invigorating, and Fructus Crataegi can be adjusted blood fat, and Flos Lonicerae can heat-clearing and toxic substances removing, above-mentioned each medicine compatibility, just hitting hypertensive morbidity pathogenesis and characteristics of incidence, effectively reduce blood pressure, the blood fat that can regulate significantly patient simultaneously, slows down the atherosclerotic generation of patient.
2. the various Chinese medicines in the present invention carry out compatibility according to certain part by weight, have well brought into play the pharmacological action of various Chinese medicines, but also have played good synergism.
3. the various Chinese medicines in the present invention are the general types of the field of Chinese medicines, abundant raw material, in preparation method of the present invention, first extracts Chinese medicine, reconcentration, finally carry out eluting, can effectively remove various impurity in Chinese medicine, not only effectively improved the purity of Chinese medicine, and avoided the infringement of all kinds of impurity to user, and preparation method of the present invention is simple, can make multiple dosage form, meet patient's different demands.
Medicine of the present invention nontoxic, have no side effect, and hyperpietic needs the medication of long-term rule, therefore, the present invention is especially applicable to hyperpietic's long-term taking.
The specific embodiment
Now the present invention is further detailed explanation in conjunction with the embodiments:
Embodiment 1
A Chinese hypotensor, described Chinese hypotensor is comprised of the Chinese medicine of following weight portion proportioning:
Described promoting blood circulation to remove obstruction in the collateral class is Radix Curcumae, and described nourishing YIN for suppressing the hyperactive YANG class is Concha Ostreae, and described diuresis class is Rhizoma Alismatis.
A preparation method for above-mentioned Chinese hypotensor, comprises the following steps:
(1) take by weight 5 parts of promoting blood circulation to remove obstruction in the collateral classes, 5 parts of nourishing YIN for suppressing the hyperactive YANG classes, 8 parts of diuresis classes, 5 parts of Semen Cassiaes, 4 parts of Flos Loniceraes, 2 parts of Spica Prunellaes, 1 part of the Radix Astragali, 5 parts of Semen Sterculiae Lychnophoraes, 3 parts of Fructus Crataegis, be ground into fine powder, cross 60 mesh sieves, add purified water to extract, the temperature of extracting is 65 ℃, the time of extracting is 30min, obtains extracting solution;
(2) in the extracting solution making in step (1), add 45% alcoholic solution solvent to carry out filtering and concentrating, concentrated temperature is 65 ℃, and the concentrated time is 30min, to remove impurity, obtains concentrated solution;
(3) to the concentrated solution making in step (2), adopt macroporous adsorptive resins to carry out eluting, the alcoholic solution that the desorbing agent of employing is 20%, elution flow rate is 0.6BV/h, and elution time is 20min, and eluting temperature is 50 ℃, and eluting 2 times, obtains eluent;
(4) eluent making in step (3) is dried and makes Chinese medicinal powder;
(5) Chinese medicinal powder making in step (4) is processed, made pill.
Embodiment 2
A Chinese hypotensor, described Chinese hypotensor is comprised of the Chinese medicine of following weight portion proportioning:
Described promoting blood circulation to remove obstruction in the collateral class is Rhizoma Chuanxiong, and described nourishing YIN for suppressing the hyperactive YANG class is Os Draconis, and described diuresis class is Poria.
A preparation method for above-mentioned Chinese hypotensor, comprises the following steps:
(1) take by weight 12 parts of promoting blood circulation to remove obstruction in the collateral classes, 10 parts of nourishing YIN for suppressing the hyperactive YANG classes, 15 parts of diuresis classes, 12 parts of Semen Cassiaes, 8 parts of Flos Loniceraes, 5 parts of Spica Prunellaes, 5 parts of the Radixs Astragali, 8 parts of Semen Sterculiae Lychnophoraes, 8 parts of Fructus Crataegis, be ground into fine powder, cross 60 mesh sieves, add purified water to extract, the temperature of extracting is 80 ℃, the time of extracting is 45min, obtains extracting solution;
(2) in the extracting solution making in step (1), add 50% alcoholic solution to carry out filtering and concentrating, concentrated temperature is 80 ℃, and the concentrated time is 45min, to remove impurity, obtains concentrated solution;
(3) to the concentrated solution making in step (2), adopt macroporous adsorptive resins to carry out eluting, the alcoholic solution that the desorbing agent of employing is 30%, elution flow rate is 0.8BV/h, and elution time is 30min, and eluting temperature is 60 ℃, and eluting 2 times, obtains eluent;
(4) eluent making in step (3) is dried and makes Chinese medicinal powder;
(5) Chinese medicinal powder making in step (4) is processed, made tablet.
Embodiment 3
A Chinese hypotensor, described Chinese hypotensor is comprised of the Chinese medicine of following weight portion proportioning:
Described promoting blood circulation to remove obstruction in the collateral class is Rhizoma Corydalis.
Described nourishing YIN for suppressing the hyperactive YANG class is Concha Ostreae and Os Draconis, and the ratio of described Concha Ostreae and the weight portion of Os Draconis is 1.5:2.
Described diuresis class is Folium Nelumbinis.
A preparation method for above-mentioned Chinese hypotensor, comprises the following steps:
(1) take by weight 8 parts of promoting blood circulation to remove obstruction in the collateral classes, 7 parts of nourishing YIN for suppressing the hyperactive YANG classes, 10 parts of diuresis classes, 8 parts of Semen Cassiaes, 6 parts of Flos Loniceraes, 3.5 parts of Spica Prunellaes, 3 parts of the Radixs Astragali, 5.5 parts of Semen Sterculiae Lychnophoraes, 5.5 parts of Fructus Crataegis, be ground into fine powder, cross 60 mesh sieves, add purified water to extract, the temperature of extracting is 75 ℃, the time of extracting is 35min, obtains extracting solution;
(2) in the extracting solution making in step (1), add 48% alcoholic solution to carry out filtering and concentrating, concentrated temperature is 75 ℃, and the concentrated time is 35min, to remove impurity, obtains concentrated solution;
(3) to the concentrated solution making in step (2), adopt macroporous adsorptive resins to carry out eluting, the alcoholic solution that the desorbing agent of employing is 25%, elution flow rate is 0.7BV/h, and elution time is 25min, and eluting temperature is 55 ℃, and eluting 2 times, obtains eluent;
(4) eluent making in step (3) is dried and makes Chinese medicinal powder;
(5) Chinese medicinal powder making in step (4) is processed, made capsule.
Embodiment 4
A Chinese hypotensor, described Chinese hypotensor is comprised of the Chinese medicine of following weight portion proportioning:
Described promoting blood circulation to remove obstruction in the collateral class is Radix Curcumae, Rhizoma Chuanxiong, Rhizoma Corydalis, the Radix Paeoniae Alba and Radix Salviae Miltiorrhizae, and the ratio of the weight portion of described Radix Curcumae, Rhizoma Chuanxiong, Rhizoma Corydalis, the Radix Paeoniae Alba and Radix Salviae Miltiorrhizae is 3:5:3.5:4.5:6.
Described nourishing YIN for suppressing the hyperactive YANG class is Concha Ostreae and Os Draconis, and the ratio of described Concha Ostreae and the weight portion of Os Draconis is 5.5:5.
Described diuresis class is Rhizoma Alismatis, Radix Rehmanniae Preparata, Poria, Folium Nelumbinis or Exocarpium Benincasae, and the ratio of the weight portion of described Rhizoma Alismatis, Radix Rehmanniae Preparata, Poria, Folium Nelumbinis and Exocarpium Benincasae is 5:5:5.5:4.5:4.5.
A preparation method for above-mentioned Chinese hypotensor, comprises the following steps:
(1) take by weight 8 parts of promoting blood circulation to remove obstruction in the collateral classes, 7 parts of nourishing YIN for suppressing the hyperactive YANG classes, 10 parts of diuresis classes, 8 parts of Semen Cassiaes, 6 parts of Flos Loniceraes, 3.5 parts of Spica Prunellaes, 3 parts of the Radixs Astragali, 5.5 parts of Semen Sterculiae Lychnophoraes, 5.5 parts of Fructus Crataegis, be ground into fine powder, cross 60 mesh sieves, add purified water to extract, the temperature of extracting is 75 ℃, the time of extracting is 35min, obtains extracting solution;
(2) in the extracting solution making in step (1), add 48% alcoholic solution to carry out filtering and concentrating, concentrated temperature is 75 ℃, and the concentrated time is 35min, to remove impurity, obtains concentrated solution;
(3) to the concentrated solution making in step (2), adopt macroporous adsorptive resins to carry out eluting, the alcoholic solution that the desorbing agent of employing is 25%, elution flow rate is 0.7BV/h, and elution time is 25min, and eluting temperature is 55 ℃, and eluting 2 times, obtains eluent;
(4) eluent making in step (3) is dried and makes Chinese medicinal powder;
(5) Chinese medicinal powder making in step (4) is processed, made slow releasing capsule.The above embodiment is preferred embodiments of the present invention, is not to limit the scope of the present invention, and the equivalence of doing according to structure, feature and principle described in the present patent application the scope of the claims therefore all changes or modifies, and all should comprise in patent claim of the present invention.
Claims (10)
1. a Chinese hypotensor, is characterized in that, described Chinese hypotensor is comprised of the Chinese medicine of following weight portion proportioning:
2. a kind of Chinese hypotensor according to claim 1, is characterized in that, described promoting blood circulation to remove obstruction in the collateral class is selected from one or more in Radix Curcumae, Rhizoma Chuanxiong, Rhizoma Corydalis, the Radix Paeoniae Alba or Radix Salviae Miltiorrhizae.
3. a kind of Chinese hypotensor according to claim 2, is characterized in that, the ratio of the weight portion of described Radix Curcumae, Rhizoma Chuanxiong, Rhizoma Corydalis, the Radix Paeoniae Alba or Radix Salviae Miltiorrhizae is (1-3): (2-5): (1.5-3.5): (1.5-4.5): (2-6).
4. a kind of Chinese hypotensor according to claim 1, is characterized in that, described nourishing YIN for suppressing the hyperactive YANG class is selected from one or more in Concha Ostreae or Os Draconis.
5. a kind of Chinese hypotensor according to claim 1, is characterized in that, the ratio of described Concha Ostreae or the weight portion of Os Draconis is (1.5-5.5): (2-5).
6. a kind of Chinese hypotensor according to claim 1, is characterized in that, described diuresis class is selected from one or more in Rhizoma Alismatis, Radix Rehmanniae Preparata, Poria, Folium Nelumbinis or Exocarpium Benincasae.
7. a kind of Chinese hypotensor according to claim 1, is characterized in that, the ratio of the weight portion of described Rhizoma Alismatis, Radix Rehmanniae Preparata, Poria, Folium Nelumbinis or Exocarpium Benincasae is (1-5): (1-5): (3.5-5.5): (1.5-4.5): (2-4.5).
8. a preparation method for the Chinese hypotensor as described in as arbitrary in claim 1-6, is characterized in that, comprises the following steps:
(1) take by weight promoting blood circulation to remove obstruction in the collateral class 5-12 part, nourishing YIN for suppressing the hyperactive YANG class 5-10 part, diuresis class 8-15 part, Semen Cassiae 5-12 part, Flos Lonicerae 4-8 part, Spica Prunellae 2-5 part, Radix Astragali 1-5 part, Semen Sterculiae Lychnophorae 5-8 part, Fructus Crataegi 3-8 part, be ground into fine powder, cross 60 mesh sieves, add solvent to extract, obtain extracting solution;
(2) in the extracting solution making in step (1), add solvent to carry out filtering and concentrating, to remove impurity, obtain concentrated solution;
(3) to the concentrated solution making in step (2), adopt macroporous adsorptive resins to carry out eluting, eluting 2 times, obtains eluent;
(4) eluent making in step (3) is dried and makes Chinese medicinal powder;
(5) Chinese medicinal powder making in step (4) is processed, made pill, tablet capsule, slow releasing pill, slow releasing tablet, slow releasing capsule.
9. the preparation method of a kind of Chinese hypotensor according to claim 7, is characterized in that, the solvent described in step (1) is purified water, and the temperature of extraction is 65-80 ℃, and the time of extraction is 30-45min; Solvent described in step (2) is that concentration is the alcoholic solution of 45%-50%, and the temperature of concentration is 65-80 ℃, and the concentrated time is 30-45min.
10. the preparation method of a kind of Chinese hypotensor according to claim 7, it is characterized in that, the alcoholic solution that the desorbing agent adopting during eluting in step (3) is 20-30%, elution flow rate is 0.6-0.8BV/h, elution time is 20-30min, and eluting temperature is 50-60 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410011280.6A CN103705596B (en) | 2014-01-10 | 2014-01-10 | A kind of Chinese hypotensor and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410011280.6A CN103705596B (en) | 2014-01-10 | 2014-01-10 | A kind of Chinese hypotensor and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103705596A true CN103705596A (en) | 2014-04-09 |
| CN103705596B CN103705596B (en) | 2015-11-25 |
Family
ID=50399182
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410011280.6A Expired - Fee Related CN103705596B (en) | 2014-01-10 | 2014-01-10 | A kind of Chinese hypotensor and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103705596B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104206594A (en) * | 2014-08-27 | 2014-12-17 | 青岛恒波仪器有限公司 | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof |
| CN104491236A (en) * | 2014-12-11 | 2015-04-08 | 广东聚智诚科技有限公司 | Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation |
| CN104491237A (en) * | 2014-12-11 | 2015-04-08 | 广东聚智诚科技有限公司 | Use of traditional Chinese medicine preparation in preparing medicines for treating primary hypertension |
| CN104666488A (en) * | 2015-02-04 | 2015-06-03 | 邱杨清 | Blood-circulation-promoting and blood pressure-reducing traditional Chinese medicine composition using saussurea involucrate and preparation method of composition |
| CN104721530A (en) * | 2015-02-27 | 2015-06-24 | 周舜宁 | Antihypertensive traditional Chinese medicine composition |
| CN105616767A (en) * | 2014-10-29 | 2016-06-01 | 梁振权 | Traditional Chinese medicine formula for reducing blood pressure |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106344800A (en) * | 2016-11-11 | 2017-01-25 | 张仁灿 | Traditional Chinese medicine for reducing pressure and preparation method thereof |
| CN106389839A (en) * | 2016-11-11 | 2017-02-15 | 张仁灿 | Traditional Chinese medicine for lowering blood pressure and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102870918A (en) * | 2012-10-16 | 2013-01-16 | 张家港市绿色中药饮片有限公司 | Health-care tea formula |
| CN103041136A (en) * | 2013-02-02 | 2013-04-17 | 黄晶晶 | Chinese medicine preparation for treating hypertension |
| CN103463237A (en) * | 2013-08-28 | 2013-12-25 | 栾凤海 | Traditional Chinese medicine for clearing liver heat and stabilizing blood pressure |
-
2014
- 2014-01-10 CN CN201410011280.6A patent/CN103705596B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102870918A (en) * | 2012-10-16 | 2013-01-16 | 张家港市绿色中药饮片有限公司 | Health-care tea formula |
| CN103041136A (en) * | 2013-02-02 | 2013-04-17 | 黄晶晶 | Chinese medicine preparation for treating hypertension |
| CN103463237A (en) * | 2013-08-28 | 2013-12-25 | 栾凤海 | Traditional Chinese medicine for clearing liver heat and stabilizing blood pressure |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104206594A (en) * | 2014-08-27 | 2014-12-17 | 青岛恒波仪器有限公司 | Herba Taxilli health-care tea capable of lowering blood pressure and blood lipid and preparation method thereof |
| CN105616767A (en) * | 2014-10-29 | 2016-06-01 | 梁振权 | Traditional Chinese medicine formula for reducing blood pressure |
| CN104491236A (en) * | 2014-12-11 | 2015-04-08 | 广东聚智诚科技有限公司 | Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation |
| CN104491237A (en) * | 2014-12-11 | 2015-04-08 | 广东聚智诚科技有限公司 | Use of traditional Chinese medicine preparation in preparing medicines for treating primary hypertension |
| CN104666488A (en) * | 2015-02-04 | 2015-06-03 | 邱杨清 | Blood-circulation-promoting and blood pressure-reducing traditional Chinese medicine composition using saussurea involucrate and preparation method of composition |
| CN104721530A (en) * | 2015-02-27 | 2015-06-24 | 周舜宁 | Antihypertensive traditional Chinese medicine composition |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103705596B (en) | 2015-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705596B (en) | A kind of Chinese hypotensor and preparation method thereof | |
| CN102772748B (en) | Traditional Chinese medicine preparation for treating liver-depression qi-stagnation type viral myocarditis and preparation method thereof | |
| CN103990081A (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating infant jaundice | |
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN106692780B (en) | Composition for preventing and relieving diabetes and complications thereof | |
| CN105213574A (en) | A kind of Chinese medicine composition for the treatment of myocardial infarction and preparation method thereof | |
| CN102847061B (en) | Traditional Chinese medicine preparation for treating pediatric viral myocarditis and preparation method thereof | |
| CN104758711A (en) | Chinese herba preparation for treating pulmonary sarcoidosis and preparing method thereof | |
| CN106109521A (en) | A kind of Radix Notoginseng oral liquid | |
| CN102772747B (en) | Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis | |
| CN103977278A (en) | Drug for preventing and treating upper respiratory tract infection and sore throat | |
| CN103735899A (en) | Hypertension injection nursing drug and preparation method thereof | |
| CN103751547A (en) | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof | |
| CN110215485B (en) | Traditional Chinese medicine composition for treating diabetic skin ulcer and preparation method thereof | |
| CN109876127B (en) | Blood-nourishing angelica sinensis capsule and preparation method thereof | |
| CN102327533A (en) | Chinese herbal medicine for treating earliest scrofula | |
| CN103495103B (en) | Medicament for promoting digestion and strengthening spleen | |
| CN104758676A (en) | Medicine for treating damp-heat in resistance-type epigastric pain | |
| CN111759878A (en) | Traditional Chinese medicine composition for reducing blood sugar and preparation method thereof | |
| CN104771513A (en) | Traditional Chinese medicine composition for treating cholecystitis | |
| CN105147994A (en) | Traditional Chinese medicine preparation for treating diabetes and preparation method thereof | |
| CN104001041A (en) | Traditional Chinese medicine for treating cerebral infarction | |
| CN110711235A (en) | Tianshen blood pressure reducing capsule for calming liver, stopping endogenous wind, dredging collaterals, promoting qi circulation, activating blood circulation and removing blood stasis | |
| CN104127826A (en) | Traditional Chinese medicine composition for treating chronic alcoholic liver disease | |
| CN103721020A (en) | Blood circulation promoting and meridian unlocking granule for treating cerebral thrombosis and preparation method of granule |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| CB03 | Change of inventor or designer information |
Inventor after: Zheng Yuanbo Inventor before: Xiao Xiaoyu |
|
| COR | Change of bibliographic data | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20151023 Address after: 310023 Xihu District, Zhejiang Province, and the left road, No. 318, Applicant after: Zhejiang University of Science and Technology Address before: 510006 Panyu District City, Guangzhou Province, the University of Guangdong, West Ring Road, No. 230 Applicant before: Xiao Xiaoyu |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20151125 Termination date: 20170110 |